Skip to main content
Equibles

STATE STREET CORP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 93751 BOSTON, MA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$29,882,290
+$613,214 QoQ
Shares Held
3,730,623
+2.4% QoQ
Ownership
3.75%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 209 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 10% Shared 0% None 90%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. SPRY ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SPRY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,882,290 3,730,623
2026-03-31 $29,269,076 3,644,966
2025-12-31 $37,554,718 3,223,581
2025-09-30 $29,097,322 2,895,256
2025-06-30 $38,293,902 2,194,493
2025-03-31 $25,552,923 2,031,234
2024-12-31 $29,011,455 2,749,901
2024-09-30 $29,718,359 2,049,542
2024-06-30 $15,796,440 1,856,221
2024-03-31 $16,398,501 1,604,550
2023-12-31 $3,161,850 576,980
2023-09-30 $2,026,684 536,160
2023-06-30 $2,938,291 438,551
2023-03-31 $841,033 129,191
2022-12-31 $732,650 85,891
2022-09-30 $356,880 67,591
2022-06-30 $286,585 67,591
2022-03-31 $1,208,120 344,194
2021-12-31 $2,157,926 324,013
2021-09-30 $3,044,588 305,069
2021-06-30 $6,929,213 224,319
2021-03-31 $8,384,115 192,164